Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin CVitamin C (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

In vivo effect of ascorbic acid on enhancement of human natural killer cell activity

Vojdani et al., Nutrition Research, doi:10.1016/S0271-5317(05)80799-7
Jul 1993  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Vitamin C for COVID-19
6th treatment shown to reduce risk in September 2020, now with p = 0.00000002 from 73 studies, recognized in 12 countries.
Lower risk for mortality, ICU, hospitalization, and recovery.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
Analysis of 20 healthy subjects in the USA showing that vitamin C increases natural killer (NK) cell activity.
Graydon showed that a lower frequency of natural killer cells was associated with symptomatic COVID-19 infection.
Vojdani et al., 31 Jul 1993, USA, peer-reviewed, 2 authors.
This PaperVitamin CAll
IN VIVO EFFECT OF ASCORBIC ACID ON ENHANCEMENT OF HUMAN NATURAL KILLER CELL ACTIVITY
Ph.D Aristo Vojdani, Ph.D Mamdooh Ghoneum
The in vivo effect of ascorbic acid on human natural killer (NK) cell activity was determined. Twenty control healthy subjects were given ascorbic acid at a concentration of 60 mg/kg, and blood was drawn at 0,1,2,4,8, 24 and 48 hours after treatment with ascorbic acid. Peripheral Blood Lymphocyte-NK activity was measured by a 4-hr. -51Cr-release assay using K562 tumor cells as targets. Treatment with ascorbic acid was shown to have a biphasic effect on NK activity: a transient slight suppression between 1 to 2 hrs. (20% of control) was followed by a significant enhancement (an over-shoot) at 8 hrs. that was further increased at 24 hrs., then the activity returned to the normal level by 48 hrs. Changes in the activity of ascorbate treated NK cells were inversely related to the E:T ratio; namely 231%, 189%, 141% and 127% at 6:1, 12:1, 25:1 and 50:1 E:T ratio respectively. Flow cytometry analysis indicated no quantitative changes in the NK cell sub-populations post treatment with ascorbic acid in the experimental subjects as compared with control untreated subjects. Simultaneous to measurement of NK count and activity, ascorbic acid and its uptake by PBL was measured in the plasma. The uptake of the vitamin was maximized at 2-4 hours and maintained at a high level up to 24 hours. We conclude that ascorbie acid is a potent immunomodulator and its effect in enhancement of NK cytotoxicity may explain one mechanism by which ascorbic acid exerts its probable anti cancer activity.
References
Balkwill, Antitumor effects of interferons in animals
Buiatti, Palli, Decarli, Amadori, Avellini et al., A Case-controlled study of gastric cancer and diet in Italy: II Association with nutrients, Int. J. Cancer
Campbell, The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic supplements in advanced human cancer, Chemicalbiological Interactions
Fletcher, Baron, Asman, Fischi, Limas, Use of whole blood methods in assessment of immune paramenters in immunodefieiency states, Diagn. Clin. Immunol
Ghoneum, Gill, Wojdani, Payne, Alfred, Suppression of basal and corynebaeterium parvum-augmented NK activity during chemically induced tumor development, International Journal Immunophar
Ghoneum, Salem, Gill, Jackson, Betru et al., NK cell activity and tumor development of age-related variation to 3-methylcholanthrene
Henson, Block, Levine, Ascorbic acid: Biologic functions and relation to cancer, J. National Cancer Institute
Herberman, Poss~le role of natural killer cells in host resistance against tumors and diseases, Clin. Immun Allergy
Howe, Gr, Hirohata, Hislop, Iscovich et al., Dietary factors and the risk of breast cancer: combined analysis of 12 case-controlled studies, JNCI
Huwyler, Hirt, Morell, Effect of ascorbic acid on human natural killer cells, Immunology Letters
Irwin, Hutchins, A conspectus of research on vitamin C requirements of man, J. Nutr
Jondal, The human NK cell-a short over-view and an hypothesis on NK recognition, Clin Exp Immunol
Lotzova, Savary, Herberman, Induction of NK cells activity against fresh human leukemia in culture with interleukin 2, J. Immunol
Moertal, Fleming, Creagan, Rubin, Connell et al., High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who had no prior chemotherapy, New England Journal of Medicine
Nino, Prasad, In: Gradwohl's Clinical Laboratory Methods and Diagnosis (Sonnenwirth AC and Jarett L Eds) Volume One. The C.V. Mosby Comp
Pauling, Ascorbie acid and the glyeosaminoglycans: An orthomolecular approach to cancer and other diseases, Oneology
Pauling, Supplemental aseorbate in the supportive treatment of cancer; prolongation of survival times in terminal human cancer, Proe. National Academy Sciences USA
Roder, Pross, The biology of human natural killer cell, J. Clin. Immun
Siegel, Enhancement of interferon production by poly (rI), poly (rC) in mouse cell cultures by aseorbie acid, Nature (Lond)
Slaga, Bracken, The effects of antioxidants on skin tumor initiation and aryl hydrocarbon hydroxylase, Cancer Res
Whiteside, Bryant, Day, Herberman, Natural Killer cytotoxicity in the diagnosis of immune dysfunction: Criteria for a reproduc~le assay, J Clin Lab Analysis
{ 'indexed': {'date-parts': [[2023, 8, 31]], 'date-time': '2023-08-31T04:37:44Z', 'timestamp': 1693456664490}, 'reference-count': 24, 'publisher': 'Elsevier BV', 'issue': '7', 'license': [ { 'start': { 'date-parts': [[1993, 7, 1]], 'date-time': '1993-07-01T00:00:00Z', 'timestamp': 741484800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[1993, 7]]}, 'DOI': '10.1016/s0271-5317(05)80799-7', 'type': 'journal-article', 'created': {'date-parts': [[2006, 6, 7]], 'date-time': '2006-06-07T02:55:54Z', 'timestamp': 1149648954000}, 'page': '753-764', 'source': 'Crossref', 'is-referenced-by-count': 27, 'title': 'In vivo effect of ascorbic acid on enhancement of human natural killer cell activity', 'prefix': '10.1016', 'volume': '13', 'author': [ {'given': 'Aristo', 'family': 'Vojdani', 'sequence': 'first', 'affiliation': []}, {'given': 'Mamdooh', 'family': 'Ghoneum', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/S0271-5317(05)80799-7_bib1', 'doi-asserted-by': 'crossref', 'first-page': '694', 'DOI': '10.1056/NEJM198003203021219', 'article-title': 'Vitamin C therapy of advanced cancer', 'volume': '302', 'author': 'Pauling', 'year': '1980', 'journal-title': 'New Engl. J. Med'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib2', 'first-page': '179', 'article-title': 'Vitamin C and Immunity: Natural Killer (NK) cell factor', 'volume': '53', 'author': 'Siegel', 'year': '1983', 'journal-title': 'Int. J. Vitam Nutr. Res'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib3', 'doi-asserted-by': 'crossref', 'first-page': '547', 'DOI': '10.1093/jnci/83.8.547', 'article-title': 'Ascorbic acid: Biologic functions and relation to cancer', 'volume': '83', 'author': 'Henson', 'year': '1991', 'journal-title': 'J. National Cancer Institute'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib4', 'doi-asserted-by': 'crossref', 'first-page': '71', 'DOI': '10.1016/0192-0561(87)90112-3', 'article-title': 'Suppression of basal and corynebacterium parvum-augmented NK activity ' 'during chemically induced tumor development', 'volume': '9', 'author': 'Ghoneum', 'year': '1987', 'journal-title': 'International Journal Immunophar'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib5', 'series-title': 'natural Killer Cells and Host Defense', 'first-page': '278', 'article-title': 'NK cell activity and tumor development of age-related variation to ' '3-methylcholanthrene', 'author': 'Ghoneum', 'year': '1989'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib6', 'doi-asserted-by': 'crossref', 'first-page': '479', 'DOI': '10.1016/S0260-4639(22)00280-8', 'article-title': 'Possible role of natural killer cells in host resistance against tumors ' 'and diseases', 'volume': '3', 'author': 'Herberman', 'year': '1983', 'journal-title': 'Clin. Immun Allergy'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib7', 'first-page': '255', 'article-title': 'The human NK cell-a short over-view and an hypothesis on NK recognition', 'volume': '70', 'author': 'Jondal', 'year': '1987', 'journal-title': 'Clin Exp Immunol'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib8', 'doi-asserted-by': 'crossref', 'first-page': '249', 'DOI': '10.1007/BF00915064', 'article-title': 'The biology of human natural killer cell', 'volume': '2', 'author': 'Roder', 'year': '1983', 'journal-title': 'J. Clin. Immun.'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib9', 'doi-asserted-by': 'crossref', 'first-page': '102', 'DOI': '10.1002/jcla.1860040207', 'article-title': 'Natural Killer cytotoxicity in the diagnosis of immune dysfunction: ' 'Criteria for a reproducible assay', 'volume': '4', 'author': 'Whiteside', 'year': '1990', 'journal-title': 'J Clin Lab Analysis'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib10', 'first-page': '370', 'article-title': 'Vitamins and trace elements', 'volume': 'Volume One', 'author': 'Nino', 'year': '1980'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib11', 'first-page': '69', 'article-title': 'Use of whole blood methods in assessment of immune parameters in ' 'immunodeficiency states', 'volume': '5', 'author': 'Fletcher', 'year': '1987', 'journal-title': 'Diagn. Clin. Immunol.'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib12', 'doi-asserted-by': 'crossref', 'first-page': '173', 'DOI': '10.1016/0165-2478(85)90073-2', 'article-title': 'Effect of ascorbic acid on human natural killer cells', 'volume': '10', 'author': 'Huwyler', 'year': '1985', 'journal-title': 'Immunology Letters'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib13', 'doi-asserted-by': 'crossref', 'first-page': '2718', 'DOI': '10.4049/jimmunol.138.8.2718', 'article-title': 'Induction of NK cells activity against fresh human leukemia in culture ' 'with interleukin 2', 'volume': '138', 'author': 'Lotzova', 'year': '1987', 'journal-title': 'J. Immunol'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib14', 'first-page': '231', 'article-title': 'Enhancement of interferon production by poly (rI), poly (rC) in mouse ' 'cell cultures by ascorbic acid', 'volume': '234', 'author': 'Siegel', 'year': '1975', 'journal-title': 'Nature (Lond)'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib15', 'first-page': '23', 'article-title': 'Antitumor effects of interferons in animals', 'author': 'Balkwill', 'year': '1985'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib16', 'doi-asserted-by': 'crossref', 'first-page': '821', 'DOI': '10.1093/jn/106.6.821', 'article-title': 'A conspectus of research on vitamin C requirements of man', 'volume': '106', 'author': 'Irwin', 'year': '1976', 'journal-title': 'J. Nutr.'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib17', 'doi-asserted-by': 'crossref', 'first-page': '285', 'DOI': '10.1016/0009-2797(74)90019-2', 'article-title': 'The orthomolecular treatment of cancer. II. Clinical trial of high-dose ' 'ascorbic supplements in advanced human cancer', 'volume': '9', 'author': 'Cameron', 'year': '1974', 'journal-title': 'Chemical-biological Interactions'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib18', 'doi-asserted-by': 'crossref', 'first-page': '181', 'DOI': '10.1159/000224733', 'article-title': 'Ascorbic acid and the glycosaminoglycans: An orthomolecular approach to ' 'cancer and other diseases', 'volume': '27', 'author': 'Cameron', 'year': '1973', 'journal-title': 'Oncology'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib19', 'doi-asserted-by': 'crossref', 'first-page': '3685', 'DOI': '10.1073/pnas.73.10.3685', 'article-title': 'Supplemental ascorbate in the supportive treatment of cancer; ' 'prolongation of survival times in terminal human cancer', 'volume': '73', 'author': 'Cameron', 'year': '1976', 'journal-title': 'Proc. National Academy Sciences USA'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib20', 'doi-asserted-by': 'crossref', 'first-page': '137', 'DOI': '10.1056/NEJM198501173120301', 'article-title': 'High-dose vitamin C versus placebo in the treatment of patients with ' 'advanced cancer who had no prior chemotherapy', 'volume': '312', 'author': 'Moertal', 'year': '1985', 'journal-title': 'New England Journal of Medicine'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib21', 'doi-asserted-by': 'crossref', 'first-page': '9', 'DOI': '10.1111/j.1600-0609.1990.tb00340.x', 'article-title': 'Characterization of anew malignant human T-cell line (PFI-285) ' 'sensitive to ascorbic acid', 'volume': '44', 'author': 'Helgestad', 'year': '1990', 'journal-title': 'Eur J. Haematol'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib22', 'first-page': '1631', 'article-title': 'The effects of antioxidants on skin tumor initiation and aryl ' 'hydrocarbon hydroxylase', 'volume': '37', 'author': 'Slaga', 'year': '1977', 'journal-title': 'Cancer Res'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib23', 'doi-asserted-by': 'crossref', 'first-page': '561', 'DOI': '10.1093/jnci/82.7.561', 'article-title': '“Dietary factors and the risk of breast cancer: combined analysis of 12 ' 'case-controlled studies”', 'volume': '82', 'author': 'Howe', 'year': '1990', 'journal-title': 'JNCI'}, { 'key': '10.1016/S0271-5317(05)80799-7_bib24', 'doi-asserted-by': 'crossref', 'first-page': '896', 'DOI': '10.1002/ijc.2910450520', 'article-title': '“A Case-controlled study of gastric cancer and diet in Italy: II ' 'Association with nutrients”', 'volume': '45', 'author': 'Buiatti', 'year': '1990', 'journal-title': 'Int. J. Cancer'}], 'container-title': 'Nutrition Research', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0271531705807997?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0271531705807997?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2023, 5, 7]], 'date-time': '2023-05-07T16:56:44Z', 'timestamp': 1683478604000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0271531705807997'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[1993, 7]]}, 'references-count': 24, 'journal-issue': {'issue': '7', 'published-print': {'date-parts': [[1993, 7]]}}, 'alternative-id': ['S0271531705807997'], 'URL': 'http://dx.doi.org/10.1016/S0271-5317(05)80799-7', 'relation': {}, 'ISSN': ['0271-5317'], 'subject': ['Nutrition and Dietetics', 'Endocrinology', 'Endocrinology, Diabetes and Metabolism'], 'container-title-short': 'Nutrition Research', 'published': {'date-parts': [[1993, 7]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit